Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 21Sexual function and dysfunction studiesPhosphodiesterase function and regulationUrinary Bladder and Prostate Research

The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.

Tadalafil: a novel treatment for erectile dysfunction

GIULIANO, F·2002·European Heart Journal Supplements

Abstract

Tadalafil, a potent, selective and reversible inhibitor of phosphodiesterase type 5 that is under review as an oral therapy for erectile dysfunction, has a time to maximum concentration of 2 h and a half-life of 17·5 h. Systemic tadalafil exposure was not clinically significantly altered by age or diabetes. Food did not alter the rate and extent of absorption of tadalafil, and no restrictions regarding food or alcohol intake were imposed on patients in tadalafil clinical trials. Furthermore, the time of dosing had no significant effect on the systemic distribution of tadalafil. Integrated analyses of data from five phase III trials demonstrated that tadalafil at doses from 5 mg to 20 mg significantly improved erectile function (vs placebo) by all efficacy measures. Tadalafil was safe and well tolerated in the phase III studies, with headache and dyspepsia being the most frequent adverse events. Additionally, in a separate study of patients with erectile dysfunction and diabetes, tadalafil 10 mg and 20 mg significantly improved all efficacy measures as compared with placebo.

Overview

Integrity signals

Registry

Crossref · 10.1016/s1520-765x(02)90049-0

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 22 references

Cited by

See all 21

Metadata

Authors
GIULIANO, F.
Affiliations
Bicêtre Hospital (FR)
Corresponding author
GIULIANO, F
Venue
European Heart Journal Supplements
Published
2002-12
Volume
4
Pages
H24-H31
ISSN
1520-765X (ISSN-L)
OpenAlex
W2097718744
Cited by
21
References
22
Citations by year
2024: 1 · 2022: 2 · 2020: 2 · 2014: 1
FWCI
1.65
Type
journal article
Language
en
Open access
closed
Locations
European Heart Journal Supplements (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Sexual function and dysfunction studies
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Phosphodiesterase function and regulation
  • Health Sciences › Medicine › Urology › Urinary Bladder and Prostate Research
Keywords
tadalafil, erectile dysfunction, phosphodiesterase-5 inhibitors, oral therapy, pharmacokinetics, timing of drug administration, diabetes mellitus, erectile function, drug safety, adverse events

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Tadalafil: a novel treatment for erectile dysfunction. https://app.cochat.ai/papers/10.1016/s1520-765x(02)90049-0
The paper
GIULIANO, F. (2002). Tadalafil: a novel treatment for erectile dysfunction. European Heart Journal Supplements. https://doi.org/10.1016/s1520-765x(02)90049-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.